Dong Jin Suh

Summary

Affiliation: University of Ulsan
Country: Korea

Publications

  1. pmc Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B
    Dong Jin Suh
    Asan Medical Center, University of Ulsan, Seoul, South Korea
    Antimicrob Agents Chemother 54:1242-7. 2010
  2. doi request reprint rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
    Yoon Seon Lee
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    J Gastroenterol Hepatol 27:300-5. 2012
  3. doi request reprint Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors
    Young Joo Jin
    Department of Internal Medicine, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 27:1341-7. 2012
  4. doi request reprint Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
    Ju Hyun Shim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Hepatology 50:1064-71. 2009
  5. doi request reprint Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
    Nae Yun Heo
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    J Hepatol 53:449-54. 2010
  6. doi request reprint Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy
    Yoon Seon Lee
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Liver Int 29:552-6. 2009
  7. doi request reprint Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes
    Sang Min Yoon
    Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    Int J Radiat Oncol Biol Phys 82:2004-11. 2012
  8. doi request reprint Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma
    Young Joo Jin
    Department of Internal Medicine, Asan Medical Center, Asan Liver Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 26:1380-8. 2011
  9. doi request reprint [Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b]
    Young Joo Jin
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Korean J Hepatol 16:158-67. 2010
  10. ncbi request reprint Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy
    Myoung Kuk Jang
    Department of Internal Medicine, Research Institute for Digestive Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 19:1363-8. 2004

Collaborators

Detail Information

Publications54

  1. pmc Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B
    Dong Jin Suh
    Asan Medical Center, University of Ulsan, Seoul, South Korea
    Antimicrob Agents Chemother 54:1242-7. 2010
    ..No differences in the effects of these 2 agents on early viral kinetics were observed. Both medications were well tolerated...
  2. doi request reprint rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
    Yoon Seon Lee
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    J Gastroenterol Hepatol 27:300-5. 2012
    ....
  3. doi request reprint Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors
    Young Joo Jin
    Department of Internal Medicine, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 27:1341-7. 2012
    ..We evaluated efficacy of exercise and diet modification for steatosis improvement of non-obese non-alcoholic fatty liver disease (NAFLD) patients...
  4. doi request reprint Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
    Ju Hyun Shim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Hepatology 50:1064-71. 2009
    ..18 versus -0.97 and -5.37 versus -2.15 log(10) copies/mL, respectively; both P < 0.05)...
  5. doi request reprint Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
    Nae Yun Heo
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    J Hepatol 53:449-54. 2010
    ..Little is known about the optimal management of patients with chronic hepatitis B (CHB) who developed multiple-drug resistance...
  6. doi request reprint Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy
    Yoon Seon Lee
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Liver Int 29:552-6. 2009
    ..We intended to examine the effects of these genotypic variants on the antiviral efficacy of adefovir dipivoxil (ADV) therapy...
  7. doi request reprint Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes
    Sang Min Yoon
    Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    Int J Radiat Oncol Biol Phys 82:2004-11. 2012
    ..We have evaluated the clinical outcomes of patients after transarterial chemoembolization (TACE) and 3-dimensional conformal radiotherapy for hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT)...
  8. doi request reprint Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma
    Young Joo Jin
    Department of Internal Medicine, Asan Medical Center, Asan Liver Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 26:1380-8. 2011
    ..We investigated the efficacy and effectiveness of entecavir in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) patients...
  9. doi request reprint [Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b]
    Young Joo Jin
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Korean J Hepatol 16:158-67. 2010
    ..We examined the pattern of ISDR mutations and analyzed whether the number of amino acid substitutions influences the treatment response to peginterferon plus ribavirin in chronic hepatitis or cirrhotic patients infected with HCV-Ib...
  10. ncbi request reprint Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy
    Myoung Kuk Jang
    Department of Internal Medicine, Research Institute for Digestive Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 19:1363-8. 2004
    ..In this study, we investigated the effects of alpha-interferon (IFN-alpha) combined with lamivudine on the occurrence of viral breakthrough during long-term lamivudine therapy...
  11. ncbi request reprint Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study
    Soo Hyung Ryu
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388 1 Poongnap dong Songpa ku, 138 040, Seoul, South Korea
    J Hepatol 39:614-9. 2003
    ..In this prospective study, the authors intended to investigate whether long-term additional administration of lamivudine might enhance the durability of lamivudine-induced HBeAg seroconversion...
  12. ncbi request reprint Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
    Yoon Seon Lee
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Hepatology 43:1385-91. 2006
    ....
  13. doi request reprint Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection
    Ju Hyun Shim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Ann Surg Oncol 17:869-77. 2010
    ....
  14. doi request reprint Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion
    Kang Mo Kim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 24:806-14. 2009
    ..This study aimed to evaluate the therapeutic efficacy and safety of repeated transarterial chemoembolization (TACE) with additional radiation therapy (RT) in hepatocellular carcinoma (HCC) with portal vein (PV) invasion...
  15. doi request reprint Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy
    Shin Hwang
    Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Liver Transpl 14:770-8. 2008
    ..Our posttransplant HBV prophylaxis regimen resulted in a 5-year HBV recurrence rate of 7.3% and a mortality rate of 13.2% after HBV recurrence, showing the effectiveness of high-dose HBIG monotherapy and rescue antiviral therapy...
  16. doi request reprint Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis
    Ju Hyun Shim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    J Hepatol 52:176-82. 2010
    ..The effect of entecavir (ETV) therapy on viral suppression and hepatic function in hepatitis B virus (HBV) patients with decompensated cirrhosis has not been established. We evaluated ETV as first-line monotherapy in these patients...
  17. pmc Randomized trial of the virologic response during up to two years of entecavir-adefovir combination therapy in multiple-drug-refractory chronic hepatitis B virus patients
    Young Suk Lim
    Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    Antimicrob Agents Chemother 57:3369-74. 2013
    ..This study has been registered at ClinicalTrials.gov under registration no. NCT01023217.)...
  18. pmc Clinical course of chronic hepatitis B patients who were off-treated after lamivudine treatment: analysis of 138 consecutive patients
    Young Joo Jin
    Department of Internal Medicine, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic ro 43 gil, Songpa Gu, Seoul, 138 736, South Korea
    Virol J 9:239. 2012
    ..We intended to analyze the long-term outcome of CHB patients who discontinued lamivudine therapy and to evaluate predictors for post-treatment outcome...
  19. doi request reprint Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues
    Young Suk Lim
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Antivir Ther 17:53-60. 2012
    ..The combination of entecavir, a nucleoside analogue, and adefovir, a nucleotide analogue, would be a promising salvage treatment for chronic hepatitis B (CHB) patients who fail nucleoside/nucleotide analogue (NA) regimens...
  20. ncbi request reprint Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma
    Sang Hyo Shin
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Centre, Seoul, South Korea
    Eur J Gastroenterol Hepatol 16:319-24. 2004
    ..Considering the pathophysiological mechanism of BCS, BCS-associated HCC may have a different carcinogenic process to hepatitis B virus (HBV)-associated HCC, resulting in different characteristic clinical features...
  21. doi request reprint Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area
    Soo Jung Park
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Hepatology 51:903-11. 2010
    ....
  22. pmc Randomized trial of entecavir plus adefovir in patients with lamivudine-resistant chronic hepatitis B who show suboptimal response to lamivudine plus adefovir
    Young Suk Lim
    Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    Antimicrob Agents Chemother 56:2941-7. 2012
    ....
  23. pmc Could HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?
    Yoon Kyung Park
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Korean Med Sci 26:214-21. 2011
    ..Future experiments are needed to understand the role of HBx protein expression in HCC treatment using molecular targeting agent...
  24. doi request reprint Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus
    Ja Eun Koo
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Int J Radiat Oncol Biol Phys 78:180-7. 2010
    ..To evaluate the effects of transarterial chemoembolization (TACE) and three-dimensional conformal radiotherapy (CRT) in patients with hepatocellular carcinoma (HCC) and inferior vena cava tumor thrombus (IVCTT)...
  25. doi request reprint A nationwide seroepidemiology of hepatitis C virus infection in South Korea
    Do Young Kim
    Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
    Liver Int 33:586-94. 2013
    ..The aim of this study was to reveal nationwide seroprevalence of HCV infection in South Korea by a large-scale survey...
  26. doi request reprint Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area
    Sung Eun Kim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Liver Int 31:1468-76. 2011
    ....
  27. ncbi request reprint Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea
    Young Hwan Park
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 18:927-33. 2003
    ..The present study investigated the changing pattern of antibiotic resistance and its effects on the clinical outcome in treating SBP...
  28. pmc Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center
    Sung Eun Kim
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Korean J Hepatol 17:113-9. 2011
    ..This study evaluated the applicability of the BCLC staging system and reasons for divergence from BCLC-recommended treatments in Korean HCC patients...
  29. doi request reprint Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt
    Ja Eun Koo
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Korean J Hepatol 14:89-96. 2008
    ..One patient experienced improved neurologic symptoms after liver transplantation, whereas the other patient only received medical treatment, which did not prevent the progression of spastic paraparesis...
  30. doi request reprint Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism
    Heung Bum Oh
    Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
    J Med Virol 80:1712-9. 2008
    ..The ability of the RFMP assay to differentiate various HCV genotypes should enable better analysis of the relationship between HCV genotype and disease prognosis...
  31. ncbi request reprint Current status of hepatitis C virus infection in Korea
    Dong Jin Suh
    Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Intervirology 49:70-5. 2006
    ..After the successful program of hepatitis B vaccination, HCV infection is now emerging as an important etiology of chronic liver disease in Korea, which warrants more detailed and large-scale studies...
  32. doi request reprint Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology
    Jae Keun Lee
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Hepatology 51:1577-83. 2010
    ..Age, BMI, and/or other metabolic parameters significantly affect ALT levels, even in subjects with normal livers...
  33. ncbi request reprint Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization
    Myoung Kuk Jang
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    J Gastroenterol Hepatol 19:1074-80. 2004
    ..We therefore prospectively analyzed the effects of additional angiography and chemoembolization on HCC recurrence and survival in patients who underwent TACE and achieved complete necrosis (CN)...
  34. doi request reprint Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma
    Ju Hyun Shim
    Department of Internal Medicine, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    J Hepatol 56:406-11. 2012
    ..We wished to establish the optimum maximum number of target lesions that need to be measured in enhancement estimations...
  35. doi request reprint Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma
    Ki Hun Kim
    Department of Hepatobiliary Surgery and Liver Transplantation, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
    Ann Surg Oncol 16:623-9. 2009
    ..We evaluated the effectiveness of surgical treatment and factors related to survival and recurrence...
  36. doi request reprint Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report
    Dong Jun Yoo
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Korean J Hepatol 16:83-8. 2010
    ..He was treated with cholestyramine resin. Six months after the treatment, he was doing well without any abdominal pain or photosensitivity...
  37. ncbi request reprint Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection
    Han Chu Lee
    Division of Gastroenterology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388 1 Pungnap song, Songpa Gu, Seoul, Korea
    Intervirology 46:388-93. 2003
    ..Therefore, OLT should be actively considered in patients with risk factors for early mortality or those without clinical improvement within the first 6 months of lamivudine treatment...
  38. ncbi request reprint [Therapeutic efficacy of transjugular intrahepatic portosystemic shunt on bleeding gastric varices]
    Hee Gon Song
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Taehan Kan Hakhoe Chi 8:448-57. 2002
    ..The purpose of this study was to determine the efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in patients with gastric variceal bleedings and predictive factors for survival...
  39. doi request reprint Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis
    Ji Young Choi
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Songpa Gu, Seoul, Korea
    J Gastroenterol Hepatol 26:1004-9. 2011
    ..We have investigated the clinical, radiological and pathological features of FNH and FNH-like lesions of the liver, with particular focus on the aspect of diagnosis...
  40. doi request reprint Sorafenib dose escalation in the treatment of advanced hepatocellular carcinoma
    Jeong Eun Kim
    Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Oncology 82:119-25. 2012
    ..We applied a dose escalation scheme to increase patient compliance and avoid AEs...
  41. pmc Current antiviral therapy for chronic hepatitis B
    Young Suk Lim
    Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea
    J Korean Med Sci 19:489-94. 2004
    ..Adefovir is also effective against lamivudine-resistant strains. This review will focus on the natural history and recently gained knowledge on the treatment of chronic hepatitis B...
  42. pmc Biochemical Rather than Virologic Response to Interferon Therapy may be More Closely Associated with Decrease of Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B
    Danbi Lee
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Gut Liver 1:49-55. 2007
    ..The authors examined whether the response to interferon (IFN) therapy can affect the development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients...
  43. doi request reprint Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function
    Jeong Eun Kim
    Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 86 Asanbyeongwon gil, Songpa Gu, Seoul 138 736, Korea
    Cancer Chemother Pharmacol 68:1285-90. 2011
    ..We compared the efficacy and safety of sorafenib in patients with Child-Pugh (CP) class B and CP class A...
  44. ncbi request reprint Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule
    Young Suk Lim
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
    J Hepatol 48:133-9. 2008
    ..We aimed to identify the specific HLA alleles that are susceptible to type 1 AIH in Koreans, and to validate the shared epitope hypothesis in this single ethnic group...
  45. ncbi request reprint [Nine cases of sporadic acute hepatitis E in Korea]
    Jeong Woo Lim
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Korean J Hepatol 12:230-6. 2006
    ..We report these as cases of acute hepatitis E. These cases suggest that HEV infection occurs sporadically in Korea and should be considered as a cause of cryptogenic acute hepatitis...
  46. doi request reprint Clinical usefulness of endoscopic palliation in patients with biliary obstruction caused by hepatocellular carcinoma
    Jonggi Choi
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Digestion 88:87-94. 2013
    ..To evaluate the clinical usefulness of endoscopic biliary drainage (EBD) in patients with hepatocellular carcinoma (HCC)...
  47. ncbi request reprint [Clinical features of fulminant hepatic failure in a tertiary hospital with a liver transplant center in Korea]
    Nae Yun Heo
    Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
    Korean J Hepatol 12:82-92. 2006
    ..This study intended to identify the etiology and outcome of FHF in Korean adults and to examine the role of urgent living-donor liver transplantation (LDLT) for treating this unique situation...
  48. ncbi request reprint [A case of acute hepatitis a complicated by Guillain-Barré syndrome]
    Yun Jeong Bae
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Korean J Hepatol 13:228-33. 2007
    ..After 90 hospital days, he recovered in ambulatory condition with the aid of crutches. The clinical course, prognosis and the outcome of neuropathic symptoms of GBS following acute hepatitis A were relatively poor in our case...
  49. doi request reprint Adiponectin and adiponectin receptor in relation to colorectal cancer progression
    Jeong Sik Byeon
    Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Int J Cancer 127:2758-67. 2010
    ..In conclusion, AdipoR1 and AdipoR2 may be intimately related to the progression of colorectal cancer. Further studies may be warranted to assess adiponectin and its receptors as a novel target for inhibition of colorectal cancer growth...
  50. ncbi request reprint [The effects of tamoxifen on human hepatocellular carcinoma cell proliferation and transforming growth factor-beta1 expression]
    Jung Woo Shin
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Taehan Kan Hakhoe Chi 9:10-6. 2003
    ..In this study, we evaluated the effects of tamoxifen on HCC cell growth and the expression of transforming growth factor-beta1 (TGF-beta1) which had been known as an important cytokine in growth of HCC...
  51. ncbi request reprint [A case of bacteremia by Atopobium rimae in a patient with liver cirrhosis]
    Hee Young Chung
    Department of Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Korean J Lab Med 27:351-4. 2007
    ..He was treated with metronidazole and imipenem and follow-up cultures of blood were negative at days 4 and 10. To our knowledge, this is the first report of bacteremia of A. rimae...
  52. doi request reprint Efficacy and safety of pegylated interferon-α2a in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B
    Dong Jin Suh
    Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
    Antivir Ther 18:765-73. 2013
    ....
  53. doi request reprint Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations
    Seung Soo Lee
    Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
    J Hepatol 52:579-85. 2010
    ....
  54. ncbi request reprint [Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea]
    Saera Jung
    Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
    Taehan Kan Hakhoe Chi 8:418-27. 2002
    ..The aim of this study is to evaluate the efficacy of lamivudine in consecutively enrolled patients with decompensated cirrhosis...